![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Behning, Charlotte; Fleckenstein, Monika; Pfau, Maximilian; Adrion, Christine 
ORCID: https://orcid.org/0000-0003-2408-2533; Goerdt, Lukas; Lindner, Moritz; Schmitz-Valckenberg, Steffen; Holz, Frank G. und Schmid, Matthias
(2021):
Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation.
In: BMC Medical Research Methodology, Bd. 21, 170
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2408-2533; Goerdt, Lukas; Lindner, Moritz; Schmitz-Valckenberg, Steffen; Holz, Frank G. und Schmid, Matthias
(2021):
Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation.
In: BMC Medical Research Methodology, Bd. 21, 170
[PDF, 1MB]
Behning, Charlotte; Fleckenstein, Monika; Pfau, Maximilian; Adrion, Christine; Goerdt, Lukas; Lindner, Moritz; Schmitz-Valckenberg, Steffen; Holz, Frank G. und Schmid, Matthias
(2021):
Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation.
In: Springer Nature Medical Research Methodology, Bd. 21, Nr. 1, 170
Pfau, Maximilian; Walther, Guenther; Emde, Leon von der; Berens, Philipp; Faes, Livia; Fleckenstein, Monika; Heeren, Tjebo F. C.; Kortuem, Karsten; Kuenzel, Sandrine H.; Müller, Philipp L.; Maloca, Peter M.; Waldstein, Sebastian M.; Wintergerst, Maximilian W. M.; Schmitz-Valckenberg, Steffen; Finger, Robert P. und Holz, Frank G.
(2020):
Künstliche Intelligenz in der Augenheilkunde. Leitfaden für Ärzte zur kritischen Bewertung von Studien.
In: Ophthalmologe, Bd. 117, Nr. 10: S. 973-988
Pielen, Amelie; Feltgen, Nicolas; Hattenbach, Lars-Olof; Hoerauf, Hans; Bertelmann, Thomas; Quiering, Claudia; Voegeler, Jessica; Priglinger, Siegfried; Lang, Gabriele E.; Schmitz-Valckenberg, Steffen; Wolf, Armin und Rehak, Matus
(2020):
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials.
In: Current Eye Research, Bd. 45, Nr. 5: S. 604-614
Gale, Richard P.; Pearce, Ian; Eter, Nicole; Ghanchi, Faruque; Holz, Frank G.; Schmitz-Valckenberg, Steffen; Balaskas, Konstantinos; Burton, Ben J. L.; Downes, Susan M.; Eleftheriadis, Haralabos; George, Sheena; Gilmour, David; Hamilton, Robin; Lotery, Andrew J.; Patel, Nishal; Prakash, Priya; Santiago, Cynthia; Thomas, Saju; Varma, Deepali; Walters, Gavin; Williams, Michael; Wolf, Armin; Zakri, Rosina H.; Igwe, Franklin und Ayan, Filis
(2020):
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.
In: British Journal of Ophthalmology, Bd. 104, Nr. 4: S. 493-499
[PDF, 1MB]
Terheyden, Jan H.; Finger, Robert P.; Schmitz-Valckenberg, Steffen; Agostini, HansJürgen; Dahlke, Claudia; Kuehlewein, Laura; Lang, Gabriele E.; Pauleikhoff, Daniel; Wolf, Armin; Boettger, Michael K.; Luhmann, Ulrich F. O.; Asmus, Friedrich; Holz, Frank G.; Asmus, F.; Berger, M.; Binns, A.; Boettger, M.; Bouchet, C.; Brazier, J. E.; Butt, T.; Carapezzi, C.; Carlton, J.; Costa, M.; Crabb, D. P.; Cunha-Vaz, J.; Dunbar, H.; Durbin, M.; Finger, R.; Holz, F.; Hoyng, C.; Kraetzschmar, J.; Luhmann, U.; Luening, A.; Margaron, Ph.; Martinho, C.; Melicio, B.; Normand, G.; Rowen, D.; Rubin, G. S.; Sahel, J.; Sanchez, C. I.; Fernandes, D. Sanches; Schmid, M.; Schmitz-Valckenberg, S.; Skelly, A.; Terheyden, J.; Tufail, A.; Wojek, C. und Zamiri, P.
(2019):
MACUSTAR: Entwicklung und klinische Validierung von funktionellen, strukturellen und patientenberichteten Endpunkten bei intermediärer altersabhängiger Makuladegeneration.
In: Ophthalmologe, Bd. 116, Nr. 12: S. 1186-1193
Feltgen, Nicolas; Hattenbach, Lars-Olof; Bertelmann, Thomas; Callizo, Josep; Rehak, Matus; Wolf, Armin; Berk, Hüsnü; Eter, Nicole; Lang, Gabriele E.; Pielen, Amelie; Schmitz-Valckenberg, Steffen; Quiering, Claudia; Rose, Uwe und Hörauf, Hans
(2018):
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
In: Acta Ophthalmologica, Bd. 96, Nr. 8, E933-E941
Hattenbach, Lars-Olof; Feltgen, Nicolas; Bertelmann, Thomas; Schmitz-Valckenberg, Steffen; Berk, Hüsnü; Eter, Nicole; Lang, Gabriele E.; Rehak, Matus; Taylor, Simon R.; Wolf, Armin; Weiss, Claudia; Paulus, Eva-Maria; Pielen, Amelie und Hörauf, Hans
(2018):
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).
In: Acta Ophthalmologica, Bd. 96, Nr. 1, E10-E18
Paul, Christoph; Heun, Christine; Müller, Hans-Helge; Hörauf, Hans; Feltgen, Nicolas; Wachtlin, Joachim; Kaymak, Hakan; Mennel, Stefan; Koss, Michael Janusz; Fauser, Sascha; Maier, Mathias M.; Schumann, Ricarda G.; Müller, Simone; Chang, Petrus; Schmitz-Valckenberg, Steffen; Kazerounian, Sara; Szurman, Peter; Lommatzsch, Albrecht und Bertelmann, Thomas
(2018):
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.
In: British Journal of Ophthalmology, Bd. 102, Nr. 8: S. 1092-1097
[PDF, 987kB]
Bertelmann, Thomas; Wachtlin, Joachim; Mennel, Stefan; Koss, Michael J.; Maier, Mathias M.; Schumann, Ricarda G.; Kazerounian, Sara; Daniel, Hanna und Schmitz-Valckenberg, Steffen
(2017):
The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study.
In: Graefes Archive for Clinical and Experimental Ophthalmology, Bd. 255, Nr. 7: S. 1359-1367
Hoerauf, Hans; Feltgen, Nicolas; Weiss, Claudia; Paulus, Eva-Maria; Schmitz-Valckenberg, Steffen; Pielen, Amelie; Puri, Pankaj; Berk, Hüsnü; Eter, Nicole; Wiedemann, Peter; Lang, Gabriele E.; Rehak, Matus; Wolf, Armin; Bertelmann, Thomas und Hattenbach, Lars-Olof
(2016):
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
In: American Journal of Ophthalmology, Bd. 169: S. 258-267
Scholl, Hendrik P. N.; Fleckenstein, Monika; Fritsche, Lars G.; Schmitz-Valckenberg, Steffen; Göbel, Arno; Adrion, Christine ORCID: https://orcid.org/0000-0003-2408-2533; Herold, Christine; Keilhauer, Claudia N; Mackensen, Friederike; Mössner, Andreas; Pauleikhoff, Daniel; Weinberger, Andreas W. A.; Mansmann, Ulrich; Holz, Frank G.; Becker, Tim und Weber, Bernhard H. F.
(2009):
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD.
In: PLOS ONE 4(10), e7418 [PDF, 186kB]
ORCID: https://orcid.org/0000-0003-2408-2533; Herold, Christine; Keilhauer, Claudia N; Mackensen, Friederike; Mössner, Andreas; Pauleikhoff, Daniel; Weinberger, Andreas W. A.; Mansmann, Ulrich; Holz, Frank G.; Becker, Tim und Weber, Bernhard H. F.
(2009):
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD.
In: PLOS ONE 4(10), e7418 [PDF, 186kB]